Advertisement
UK markets closed
  • FTSE 100

    8,245.37
    -39.97 (-0.48%)
     
  • FTSE 250

    20,555.37
    -160.51 (-0.77%)
     
  • AIM

    793.53
    -3.01 (-0.38%)
     
  • GBP/EUR

    1.1773
    +0.0032 (+0.27%)
     
  • GBP/USD

    1.2724
    -0.0069 (-0.54%)
     
  • Bitcoin GBP

    54,527.85
    -1,315.02 (-2.35%)
     
  • CMC Crypto 200

    1,442.31
    -36.39 (-2.46%)
     
  • S&P 500

    5,346.99
    -5.97 (-0.11%)
     
  • DOW

    38,798.99
    -87.18 (-0.22%)
     
  • CRUDE OIL

    75.38
    -0.17 (-0.23%)
     
  • GOLD FUTURES

    2,311.10
    -79.80 (-3.34%)
     
  • NIKKEI 225

    38,683.93
    -19.58 (-0.05%)
     
  • HANG SENG

    18,366.95
    -109.85 (-0.59%)
     
  • DAX

    18,557.27
    -95.40 (-0.51%)
     
  • CAC 40

    8,001.80
    -38.32 (-0.48%)
     

Agilon (AGL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended March 2024, Agilon Health (AGL) reported revenue of $1.6 billion, up 41.2% over the same period last year. EPS came in at $0.01, compared to $0.04 in the year-ago quarter.

The reported revenue represents a surprise of -0.85% over the Zacks Consensus Estimate of $1.62 billion. With the consensus EPS estimate being -$0.02, the EPS surprise was +150.00%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Agilon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Average Medicare Advantage membership: 518,400 versus 513,855 estimated by three analysts on average.

  • Direct Contracting beneficiaries (ACO REACH): 131,000 compared to the 119,150 average estimate based on two analysts.

  • Medicare Advantage Members: 522,800 compared to the 527,365 average estimate based on two analysts.

  • Revenues- Medical services: $1.60 billion compared to the $1.61 billion average estimate based on five analysts. The reported number represents a change of +41.1% year over year.

  • Revenues- Other operating: $3.16 million versus $1.92 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +139.9% change.

View all Key Company Metrics for Agilon here>>>

Shares of Agilon have returned -6.8% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Agilon Health, Inc. (AGL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research